SECTION 535:10-9-1.2. Prospective drug review  


Latest version.
  •   Prospective drug review shall be performed by the pharmacist in all pharmacies when deemed appropriate in the pharmacist's professional judgement or when required by applicable federal or state laws or rules.
    (1)   A pharmacist shall review the patient record and each prescription drug order presented for dispensing for purposes of promoting therapeutic appropriateness by identifying the following:
    (A)   overutilization or underutilization;
    (B)   therapeutic duplication;
    (C)   drug-disease contraindications, if disease is known;
    (D)   drug-drug contraindications;
    (E)   incorrect drug dosage or duration of drug treatment;
    (F)   drug-allergy interactions;
    (G)   clinical abuse/misuse.
    (2)   Upon recognizing any of (1) (A)-(G) of this section, the pharmacist shall take appropriate steps to avoid or resolve the problem which shall, if necessary, include consultation with or notification of the prescriber.
[Source: Added at 33 Ok Reg 1774, eff 9-11-16]